Posted by & filed under Financial results.

First Quarter 2015 Income Sheet
Three months ended March 31
2015 2014
Revenues
Crowdfunding 54,394 78,055
Other 19,472 8,050
Total revenues 73,866 86,105
Operating expenses
Selling, general and administrative 409,454 274,015
Professional fees 186,670 204,713
Research and development costs 22,242 45,975
Depreciation and amortization 36,938 334
Total operating expenses 665,203 525,037
Operating loss -581,337 -438,932
Other income (expense)
Fair value adjustment derivative liability – warrants -7,274  15,264
Interest expense -2,714 -5,810
Government subsidy N/A 8,221
Gain on sale of investment in Gambitious B.V. 11,504 N/A
Other income and expense N/A -1,631
Total other income (expense) 1,516 16,044
Net loss -579,821 -422,888
Net loss attributable to non-controlling interests -12,484 -11,018
Net loss attributable to Symbid Corp. stockholders  $(566,973)  $(411,870)
Basic and diluted net loss per common stock  $(0.02)  $(0.02)
Weighted average number of shares outstanding
Basic and diluted 34,079,498 26,498,864

 

First Quarter 2015 Balance Sheet
March 31 December 31
2015 2014
Assets
Current assets
Cash $413,607  $233,068
Accounts receivable, less allowance for doubtful accounts of $8,436 and $10,718 respectively 15,946 45,070
Prepaid expenses and other current assets 91,193 53,366
Total current assets 520,746 331,504
Property and equipment – at cost, less accumulated 
Depreciation and amortization 7,020 8,480
Investment in associated companies 1,128 10,750
Intangible assets, net 885,955  1,031,692
Total assets  $1,414,849  $1,382,426
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable  $381,744  $378,023
Accrued expenses and other current liabilities 152,699 291,540
Deferred government grants  N/A N/A
Current maturities of notes payable 105,464 118,149
Total current liabilities 639,907 787,712
Notes payable, less current maturities 82,046 91,914
Derivative liability – warrants 143,663 153,154
Total liabilities 856,616 1,032,780